Clinician scientist in the Department of Family Medicine and Emergency Medicine at the University of Sherbrooke in Quebec and at the Centre intégré universitaire de santé et de services sociaux du Saguenay-Lac-Saint-Jean in Quebec.
Full Professor in the Department of Family Medicine and Emergency Medicine at the University of Montreal in Quebec, a member of the Équipe de recherche en soins de première ligne of the Centre intégré de santé et de services sociaux de Laval in Quebec, Director of the University of Montreal Primary Care Research Network, Regional Network Director for the Canadian Primary Care Sentinel Surveillance Network in Quebec, and a teacher and practising physician at the Cité de la Santé Family Medicine Teaching Unit in Laval.
Can Fam Physician. 2018 Dec;64(12):e540-e545.
To draw a portrait of drug sample management in academic primary health care settings and assess conformity to existing Canadian guidelines.
Descriptive cross-sectional survey.
All 33 family medicine teaching units (FMTUs) in Quebec that kept drug samples.
Health care professionals or FMTU staff who managed drug samples (ie, ).
Drug sample managers completed a self-administered questionnaire between February and December 2013. Questionnaires inquired about sample selection, procurement, reception, storage, inventory, and disposal. Results were compared with the Canada's Research-Based Pharmaceutical Companies (2012) and the Canadian Medical Association (2007).
All 33 FMTUs responded to the questionnaire. According to managers, no FMTUs had written selection criteria to guide sample choice. Almost one-third (30%) of FMTUs had uncontrolled access to drug sample cabinets. Even though pharmaceutical companies must distribute drug samples to authorized professionals only, these professionals were involved in the procurement and the reception of samples in 79% and 56% of FMTUs, respectively. Only 15% of FMTUs kept track of samples distributed, 82% checked expiration dates, and 85% ensured proper disposal as recommended.
The management of drug samples in the FMTUs in Quebec is heterogeneous, with many FMTUs and pharmaceutical companies not following Canadian guidelines.
描绘学术初级保健环境中药物样本管理情况,并评估其与加拿大现有指南的一致性。
描述性横断面调查。
魁北克省所有 33 个家庭医学教学单位(FMTU),这些单位都保存药物样本。
管理药物样本的医疗保健专业人员或 FMTU 工作人员(即)。
药物样本管理人员于 2013 年 2 月至 12 月期间完成了一份自我管理的问卷。问卷询问了样本选择、采购、接收、储存、库存和处置情况。结果与加拿大研究型制药公司(2012 年)和加拿大医学协会(2007 年)进行了比较。
所有 33 个 FMTU 都对问卷做出了回应。根据管理人员的说法,没有 FMTU 有书面的选择标准来指导样本选择。近三分之一(30%)的 FMTU 对药物样本柜的访问不受控制。尽管制药公司必须将药物样本分发给授权的专业人员,但这些专业人员在 79%和 56%的 FMTU 中分别参与了样本的采购和接收。只有 15%的 FMTU 跟踪分发的样本,82%的 FMTU 检查有效期,85%的 FMTU 确保按照建议进行妥善处置。
魁北克省 FMTU 中药物样本的管理存在差异,许多 FMTU 和制药公司未遵循加拿大指南。